Literature DB >> 1589036

Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi.

M J Kleijmeer1, A Kelly, H J Geuze, J W Slot, A Townsend, J Trowsdale.   

Abstract

Immune recognition of intracellular proteins is mediated by major histocompatibility complex (MHC) class I molecules that present short peptides to cytotoxic T cells. Evidence suggests that peptides arise by cleavage of proteins in the cytoplasm and are transported by a signal-independent mechanism into a pre-Golgi region of the cell, where they take part in the assembly of class I heavy chains with beta 2-microglobulin (reviewed in refs 5-7). Analysis of cells that have defects in class I molecule assembly and antigen presentation has shown that this phenotype can result from mutations in either of the two ABC transporter genes located in the class II region of the MHC. This suggested that the protein complex encoded by these two genes transports peptides from the cytosol into the endoplasmic reticulum. Here we report additional evidence by showing that the transporter complex is located in the endoplasmic reticulum membrane and is probably oriented with its ATP-binding domains in the cytosol.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1589036     DOI: 10.1038/357342a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  40 in total

1.  Association of immunoproteasomes with the endoplasmic reticulum.

Authors:  P Brooks; R Z Murray; G G Mason; K B Hendil; A J Rivett
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

2.  Identification of potential HLA class I and class II epitope precursors associated with heat shock protein 70 (HSPA).

Authors:  Pawel Stocki; Nicholas J Morris; Christian Preisinger; Xiao N Wang; Walter Kolch; Gabriele Multhoff; Anne M Dickinson
Journal:  Cell Stress Chaperones       Date:  2010-04-01       Impact factor: 3.667

3.  The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes.

Authors:  Rafal Bartoszewski; Joseph W Brewer; Andras Rab; David K Crossman; Sylwia Bartoszewska; Niren Kapoor; Cathy Fuller; James F Collawn; Zsuzsa Bebok
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

Review 4.  Functional regulation of immunoproteasomes and transporter associated with antigen processing.

Authors:  L Y Hwang; P T Lieu; P A Peterson; Y Yang
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

5.  Subpopulations of proteasomes in rat liver nuclei, microsomes and cytosol.

Authors:  A Palmer; A J Rivett; S Thomson; K B Hendil; G W Butcher; G Fuertes; E Knecht
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

6.  Identification of new TAP2 alleles in gorilla: evolution of the locus within hominoids.

Authors:  P T Loflin; P R Laud; D I Watkins; D A Lawlor
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

7.  Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen.

Authors:  L M Mylin; R H Bonneau; J D Lippolis; S S Tevethia
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Oligopeptidase B-dependent signaling mediates host cell invasion by Trypanosoma cruzi.

Authors:  E V Caler; S Vaena de Avalos; P A Haynes; N W Andrews; B A Burleigh
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

9.  Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface.

Authors:  Gregory A Graf; Wei-Ping Li; Robert D Gerard; Ingrid Gelissen; Ann White; Jonathan C Cohen; Helen H Hobbs
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

10.  Increased frequency of TAP2B in early onset pauciarticular juvenile chronic arthritis.

Authors:  R P Donn; E J Davies; P L Holt; W Thomson; W Ollier
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.